• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Aveanna Healthcare Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

    9/18/25 7:30:30 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care
    Get the next $AVAH alert in real time by email
    8-K
    0001832332false00018323322025-09-172025-09-17

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): September 17, 2025

     

    img25599489_0.jpg

     

    Aveanna Healthcare Holdings Inc.

    (Exact name of Registrant as Specified in Its Charter)

     

     

    Delaware

    001-40362

    81-4717209

    (State or Other Jurisdiction
    of Incorporation)

    (Commission File Number)

    (IRS Employer
    Identification No.)

     

     

     

     

     

    400 Interstate North Parkway SE

     

    Atlanta, Georgia

     

    30339

    (Address of Principal Executive Offices)

     

    (Zip Code)

     

    Registrant’s Telephone Number, Including Area Code: 770 441-1580

     

     

    (Former Name or Former Address, if Changed Since Last Report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:


    Title of each class

     

    Trading
    Symbol(s)

     


    Name of each exchange on which registered

    Common Stock, par value $0.01 per share

     

    AVAH

     

    The Nasdaq Stock Market LLC

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     


    Item 1.01 Entry into a Material Definitive Agreement.

    On September 17, 2025 (the "Closing Date"), Aveanna Healthcare LLC, a Delaware limited liability company (the "Borrower"), a wholly owned subsidiary of Aveanna Healthcare Holdings, Inc. (the "Company"), entered into the fourth joinder and twelfth amendment (the "Refinancing Amendment") to its First Lien Credit Agreement, dated as of March 16, 2017 (as further amended, supplemented, or otherwise modified from time to time as of the date hereof, the "Existing Credit Agreement"), among the Company, the borrowing subsidiaries party thereto, the lenders party thereto, Barclays Bank PLC as administrative agent and collateral agent (in such capacities, the "Administrative Agent"), and other agents party thereto (the Existing Credit Agreement, as amended by the Refinancing Amendment, the "Amended Credit Agreement"). The Existing Credit Agreement provided for among other things, a senior secured term loan facility (the "Existing Term Loan Facility") with an outstanding balance as of the Closing Date of $885,950,000 (the "Existing Term Loans") and a $170,330,000 senior secured revolving credit facility (the "Existing Revolving Credit Facility").

     

    The Refinancing Amendment provides for, among other things, the refinancing of the Existing Revolving Credit Facility under the Existing Credit Agreement and incremental revolving loan commitments in an aggregate principal amount of $79,670,000, resulting in total aggregate revolving loan commitments of $250,000,000 (the "2025 Refinancing Revolving Credit Facility"), a portion of which may be used for the issuance of letters of credit and swingline loans. The Refinancing Amendment additionally provides for the refinancing of the Existing Term Loans ("2025 Refinancing Term Loans") under the Existing Term Loan Facility (the "2025 Refinancing Term Facility") and an incremental senior secured term loan facility (the "2025 Incremental Term Facility"), with aggregate commitments increased by $439,050,000 (the "2025 Incremental Term Loans"). Combined, the 2025 Refinancing Term Loans and 2025 Incremental Term Loans aggregate to a total principal balance of $1,325,000,000 (the "2025 Term Loans"). The 2025 Refinancing Revolving Credit Facility and the 2025 Refinancing Term Facility replace the Existing Revolving Facility and the Existing Term Loan Facility, respectively. The maturity date for loans and commitments under the 2025 Refinancing Revolving Credit Facility is September 17, 2030. The maturity date for loans and commitments under the 2025 Refinancing Term Facility is September 17, 2032. Loans under the 2025 Refinancing Term Facility amortize at a rate equal to 1.00% per annum, payable in equal quarterly installments, and were issued with original issue discount at 99.75% of par.

     

    Proceeds from the 2025 Term Loans were used to immediately refinance in full the Existing Term Loans and the Second Lien Term Loan (as defined below in Item 1.02), to pay accrued interest through the Closing Date, and to fund working capital and general corporate purposes.

     

    The 2025 Term Loans under the Amended Credit Agreement will bear interest at a rate equal to, at the election of the Borrower, Term SOFR plus an applicable margin equal to 3.75% per annum or a base rate plus an applicable margin equal to 2.75% per annum. Loans under the 2025 Refinancing Revolving Credit Facility will bear interest at a rate equal to, at the election of the Borrower, Term SOFR, plus an applicable margin equal to 3.75% per annum or a base rate plus an applicable margin equal to 2.75% per annum, so long as the Consolidated First Lien Net Leverage Ratio (as defined in the Amended Credit Agreement) is greater than 3.90 to 1.00 as of the last day of the preceding fiscal quarter, subject to (a) a decrease of 0.25% in the event that, and for so long as, the Consolidated First Lien Net Leverage Ratio is less than or equal to 3.90 to 1.00 and greater than 3.40 to 1.00 as of the last day of the preceding fiscal quarter and (b) a decrease of 0.50% in the event that, and for so long as, the Consolidated First Lien Net Leverage Ratio is less than or equal to 3.40 to 1.00 as of the last day of the preceding fiscal quarter.

     

    The Company will pay certain fees under the Amended Credit Agreement, including (a) a commitment fee of 0.50% per annum on the undrawn portion of the 2025 Refinancing Revolving Credit Facility (subject to a step-downs to 0.375% and 0.250% at the same levels described above), (b) a letter of credit fee equal to the applicable margin per annum over Term SOFR set forth above on the average daily undrawn amount of, plus unreimbursed amounts in respect of disbursements under, letters of credit issued under the 2025 Refinancing Revolving Credit Facility, (c) a fronting fee of 0.125% per annum on the stated amount of all letters of credit issued under the 2025 Refinancing Revolving Credit Facility and (d) customary annual administration fees.

     

    Other terms and conditions in the Existing Credit Agreement were not significantly amended as part of the Refinancing Amendment.

     

    The foregoing description of the Refinancing Amendment does not purport to be complete and is qualified in its entirety by reference to the Refinancing Amendment, including exhibits thereto, which is attached as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated by reference.

    Item 1.02 Termination of a Material Definitive Agreement.

    The information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 1.02.

     

    On September 17, 2025, substantially concurrently with the Refinancing Amendment described in Item 1.01, the Borrower terminated its Second Lien Credit Agreement, dated as of December, 10, 2021, by and among the Company, the Borrower, a syndicate of lending institutions from time to time party thereto, and Barclays Bank PLC, as administrative agent and collateral agent (the "Second Lien Credit Agreement"). The Second Lien Credit Agreement provided for a second lien term loan in an aggregate principal amount of $415.0 million (the "Second Lien Term Loan"), which was secured by a second lien on certain collateral specified therein.

     


    The entirety of the Second Lien Term Loan was repaid with proceeds from the 2025 Incremental Term Loans referenced into Item 1.01.

    Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

    The information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03.

    Item 8.01 Other Events.

    On September 18, 2025, the Company issued a press release announcing the Refinancing Amendment and the Amended Credit Agreement, and the termination of the Second Lien Credit Agreement. The full text of the press release is included as Exhibit 99.1 to this Current Report on Form 8-K.

    Item 9.01 Financial Statements and Exhibits.

    (d) Exhibits.

     

    Exhibit

    Number

    Description

    10.1*

    Fourth Joinder and Twelfth Amendment to First Lien Credit Agreement dated as of September 17, 2025, among Aveanna Healthcare LLC, Aveanna Healthcare Intermediate Holdings LLC, the other credit parties thereto, the lenders party thereto, the L/C issuers party thereto, and Barclays Bank PLC, as administrative agent and swingline lender.

    99.1

     

    Press Release dated September 18, 2025.

    104

    Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

    * Pursuant to item 601(a)(5) of Regulation S-K, certain exhibits and schedules to this agreement have been omitted. The registrant agrees to furnish supplementally to the Securities and Exchange Commission a copy of any omitted exhibits or schedule upon request by the Securities and Exchange Commission.


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

     

     

    AVEANNA HEALTHCARE HOLDINGS INC.

    Date:

    September 18, 2025

    By:

    /s/ Matthew Buckhalter

     

     

     

    Matthew Buckhalter
    Chief Financial Officer
    (Principal Financial Officer)

     


    Get the next $AVAH alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AVAH

    DatePrice TargetRatingAnalyst
    9/18/2025$10.00Underweight → Neutral
    Analyst
    8/19/2025$9.50Equal Weight → Overweight
    Barclays
    8/19/2025$8.00Sell → Neutral
    UBS
    7/21/2025$6.00Hold → Buy
    Jefferies
    7/2/2025$5.50Equal Weight
    Barclays
    12/13/2023Neutral → Underweight
    JP Morgan
    11/30/2023$1.50Sell
    UBS
    5/12/2023Strong Buy → Mkt Perform
    Raymond James
    More analyst ratings

    $AVAH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Aveanna upgraded by Analyst with a new price target

    Analyst upgraded Aveanna from Underweight to Neutral and set a new price target of $10.00

    9/18/25 8:32:28 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna upgraded by Barclays with a new price target

    Barclays upgraded Aveanna from Equal Weight to Overweight and set a new price target of $9.50

    8/19/25 8:29:17 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna upgraded by UBS with a new price target

    UBS upgraded Aveanna from Sell to Neutral and set a new price target of $8.00

    8/19/25 8:29:17 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    $AVAH
    SEC Filings

    View All

    Aveanna Healthcare Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)

    9/29/25 5:15:35 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Healthcare Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

    8-K - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)

    9/18/25 7:30:30 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Aveanna Healthcare Holdings Inc.

    SCHEDULE 13G/A - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)

    8/11/25 3:19:31 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    $AVAH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Administrative Officer Reisz Edwin C. was granted 139,665 shares and covered exercise/tax liability with 49,783 shares, increasing direct ownership by 7% to 1,371,497 units (SEC Form 4)

    4/A - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)

    7/16/25 7:00:04 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Large owner J.H. Whitney Equity Partners Vii, Llc disposed of 81,882 shares (SEC Form 4)

    4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)

    7/11/25 9:17:51 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Large owner Vigano Paul R disposed of 81,882 shares (SEC Form 4)

    4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)

    7/11/25 9:14:06 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    $AVAH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aveanna to Participate at the Deutsche Bank Annual Leveraged Finance Conference

    ATLANTA, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ: AVAH) today announced that its management team will attend the Deutsche Bank Annual Leveraged Finance Conference in Austin, TX on October 15, 2025. Management will host 1x1 investor meetings that day. About Aveanna Healthcare Aveanna Healthcare is headquartered in Atlanta, Georgia and has locations in 38 states providing a broad range of pediatric and adult healthcare services including nursing, rehabilitation services, occupational nursing in schools, therapy services, day treatment centers for medically fragile and chronically ill children and adults, home health and hospice se

    9/26/25 7:30:09 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Healthcare Announces Successful Debt Refinancing

    ATLANTA, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced the closing of its refinanced first lien credit facility. The refinanced credit facility provides for the refinancing of the $886.0 million principal balance of existing first lien term loans, the additional borrowing of $439.0 million in incremental first lien term loans, and the upsize of its revolving credit facility from $170.3 million of maximum availability to $250.0 million of maximum availability. The combined $1.325 billion first lien term loans' maturity dates were extended to 2032, and the revolving credit facility's maturity date was extended from 2028 to 2030.

    9/18/25 7:30:55 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna to Participate at the Jefferies Healthcare Services Conference

    ATLANTA, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the Jefferies Healthcare Services Conference in Nashville on September 30, 2025. Management will host 1x1 investor meetings as well as a fireside chat at 3:00 p.m. Central Time on the same day, September 30, 2025. Interested investors and other parties may also listen to a simultaneous webcast of the fireside chat by logging onto the Investor Relations section of the Company's website at https://ir.aveanna.com/. The online replay will be available for a limited time shortly following the call. About Aveanna Healthcare Aveanna Healthc

    9/9/25 7:30:11 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    $AVAH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Aveanna Healthcare Holdings Inc.

    SC 13G - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)

    2/14/24 4:00:42 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by Aveanna Healthcare Holdings Inc.

    SC 13G - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)

    2/14/22 6:43:51 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    $AVAH
    Leadership Updates

    Live Leadership Updates

    View All

    Aveanna Healthcare Holdings Announces Appointment of New Director

    ATLANTA, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Brent Layton to serve as a Class III director of the Board of Directors of Aveanna Healthcare Holdings Inc., and additionally as a member of the Audit Committee of the Board, effective November 1, 2024. "I am delighted to announce the appointment of Brent Layton to our Aveanna Board of Directors. Brent brings a wealth of healthcare knowledge from over 20 years of leadership at Centene Corporation. Brent's experience working with state and feder

    11/4/24 7:30:02 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Healthcare Holdings Announces Appointment of Chief Legal Officer and Secretary

    ATLANTA, April 03, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Jerry Perchik to serve as Chief Legal Officer and Secretary, effective April 29, 2024. "I am pleased to announce the appointment of Jerry to the Chief Legal Officer and Secretary role. Jerry has a strong background in corporate law and a wealth of healthcare industry and regulatory experience. I have known Jerry for more than a decade and have great trust in his leadership and counsel. It is a pleasure to welcome Jerry to our Aveanna family, and

    4/3/24 6:30:06 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Healthcare Holdings Announces Appointment of Chief Financial Officer

    ATLANTA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Matt Buckhalter to serve as Chief Financial Officer and continuing in the role of Principal Financial Officer, effective January 1, 2024. Mr. Buckhalter was appointed to serve as Interim Chief Financial Officer and Principal Financial Officer in July, 2023. "I am pleased to announce the promotion of Matt to the Chief Financial Officer position. Matt has provided strong financial leadership and continuity as we build on our recent successes to t

    12/11/23 7:30:00 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    $AVAH
    Financials

    Live finance-specific insights

    View All

    Aveanna Healthcare Holdings Announces Second Quarter Financial Results and Revised 2025 Outlook

    Second Quarter Revenue was $589.6 million, a 16.8% increase over the prior year periodSecond Quarter Net income was $27.0 million, a 94.3% increase over the prior year periodAdjusted EBITDA for Q2 2025 was $88.4 million, a 93.6% increase over the prior year periodIncreased Full Year 2025 Revenue guidance greater than $2.3 billion, updated from greater than $2.15 billion Increased Full Year 2025 Adjusted EBITDA guidance greater than $270 million, updated from greater than $207 million ATLANTA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populat

    8/7/25 6:30:05 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Announces Second Quarter 2025 Earnings Release Date and Conference Call

    ATLANTA, July 17, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its second quarter results before the market open on Thursday, August 7, 2025, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13754011. The replay will be available until August 14, 20

    7/17/25 6:30:51 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2025 Outlook

    First Quarter Revenue was $559.2 million, a 14.0% increase over the prior year period Gross margin increased 25.9% to $183.6 million compared to Q1 2024 First Quarter Net income was $5.2 million compared to net loss of $11.2 million for the comparable prior year period Adjusted Net income was $21.4 million, an increase of $27.1 million compared to Q1 2024 Adjusted EBITDA for Q1 2025 was $67.4 million, a 93.1% increase as compared to Q1 2024Revised Full Year 2025 Revenue guidance greater than $2.15 billion, updated from a range of $2.10 - $2.12 billion Revised Full Year 2025 Adjusted EBITDA guidance greater than $207 million, updated from a range of $190 - $194 million ATLANTA, May 08, 20

    5/8/25 6:30:59 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care